| Primary |
| Promotion Of Wound Healing |
100.0% |
|
| Ageusia |
50.0% |
| Anosmia |
25.0% |
| Anaphylactic Reaction |
12.5% |
| Nausea |
12.5% |
|
| Secondary |
| Parenteral Nutrition |
40.4% |
| Product Used For Unknown Indication |
23.4% |
| Total Parenteral Nutrition |
19.1% |
| Growth Hormone Deficiency |
4.3% |
| Hepatitis B |
4.3% |
| Hypothyroidism |
4.3% |
| Hypoglycaemia |
2.1% |
| Medical Diet |
2.1% |
|
| Hypoglycaemia |
25.0% |
| Convulsion |
12.5% |
| Death |
12.5% |
| Drug Hypersensitivity |
12.5% |
| Enterobacter Infection |
12.5% |
| Product Compounding Quality Issue |
12.5% |
| Respiratory Arrest |
12.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
50.5% |
| Drug Use For Unknown Indication |
11.9% |
| Crohn's Disease |
6.4% |
| Hypertension |
3.9% |
| Pain |
3.6% |
| Multiple Myeloma |
2.4% |
| Inflammatory Bowel Disease |
2.4% |
| Supplementation Therapy |
2.0% |
| Depression |
1.9% |
| Vitamin Supplementation |
1.8% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Mineral Supplementation |
1.5% |
| Routine Health Maintenance |
1.5% |
| Prophylaxis |
1.3% |
| Osteoporosis |
1.2% |
| Nausea |
1.2% |
| Atrial Fibrillation |
1.1% |
| Insomnia |
1.1% |
| Pulmonary Arterial Hypertension |
1.1% |
|
| Vomiting |
13.8% |
| Pyrexia |
7.5% |
| Death |
6.9% |
| Renal Failure |
6.3% |
| Pneumonia |
5.7% |
| Urinary Tract Infection |
5.7% |
| Crohn's Disease |
5.0% |
| Unresponsive To Stimuli |
5.0% |
| Diarrhoea |
4.4% |
| Renal Failure Acute |
4.4% |
| Weight Decreased |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Arthralgia |
3.8% |
| Headache |
3.8% |
| Cerebrovascular Accident |
3.1% |
| Dyspnoea |
3.1% |
| Flushing |
3.1% |
| International Normalised Ratio Increased |
3.1% |
| Nausea |
3.1% |
| Retroperitoneal Abscess |
3.1% |
|
| Interacting |
| Lower Respiratory Tract Infection |
100.0% |
|
|
